KEAP1 and hepatocellular carcinoma: Genome-wide CRISPR/Cas9 screening identified that Kelch-like ECH associated protein 1 (KEAP1) mediates susceptibility to TKIs, such as sorafenib, lenvatinib, and regorafenib in HuH-7 HCC cells.